West Pharmaceutical Services IncWST
▲ PositiveCapitalrelevance
Q2 profit and revenue beat, raised guidance
Impact on stocks 1
Biotech & Genomic Medicine
West Pharmaceutical Services IncWest Pharmaceutical Services reported a second-quarter profit of $154.0 million, or $2.15 per share, up from $131.8 million, or $1.82 per share, a year earlier. Excluding items, adjusted earnings were $169.4 million, or $2.37 per share. Revenue rose 13.8% to $872.3 million from $766.5 million. The company issued guidance for the next quarter with earnings per share between $2.14 and $2.24 on revenue of $820 million to $835 million, and full-year earnings per share of $8.85 to $9.05 on revenue of $3.345 billion to $3.380 billion.
West Pharmaceutical Services IncQ2 profit and revenue beat, raised guidance